Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Mahler

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Communications Biology|March 24, 2021
Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified productLucia F Zacchi, Dinora Roche-Recinos, Cassandra L Pegg, et al.
International Journal of Molecular Sciences|August 12, 2022
Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor AntibodiesNadya Panagides, Lucia F Zacchi, Mitchell J De Souza, et al.
ACS Nano|September 16, 2020
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and TargetingAmal J Sivaram, Andri Wardiana, Sheilajen Alcantara, et al.
Lab on a Chip|November 13, 2019
Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencingLyndon J Raftery, Christopher B Howard, Yadveer S Grewal, et al.
Advanced Healthcare Materials|June 11, 2016
Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific AntibodiesChristopher B Howard, Nicholas Fletcher, Zachary H Houston, et al.
Chemical Science|June 14, 2021
Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic deliveryGayathri R Ediriweera, Joshua D Simpson, Adrian V Fuchs, et al.
Plos One|October 24, 2017
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft modelsMohamed A Alfaleh, Christopher B Howard, Ilya Sedliarou, et al.
ACS Central Science|June 4, 2020
Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific AntibodiesZachary H Houston, Jens Bunt, Kok-Siong Chen, et al.
Biomaterials|February 26, 2022
Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruptionPhillip W Janowicz, Zachary H Houston, Jens Bunt, et al.
Advanced Healthcare Materials|March 15, 2019
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific AntibodiesJiwei Cui, Yi Ju, Zachary H Houston, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Communications Biology|March 24, 2021
Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified productLucia F Zacchi, Dinora Roche-Recinos, Cassandra L Pegg, et al.
International Journal of Molecular Sciences|August 12, 2022
Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor AntibodiesNadya Panagides, Lucia F Zacchi, Mitchell J De Souza, et al.
ACS Nano|September 16, 2020
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and TargetingAmal J Sivaram, Andri Wardiana, Sheilajen Alcantara, et al.
Lab on a Chip|November 13, 2019
Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencingLyndon J Raftery, Christopher B Howard, Yadveer S Grewal, et al.
Advanced Healthcare Materials|June 11, 2016
Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific AntibodiesChristopher B Howard, Nicholas Fletcher, Zachary H Houston, et al.
Chemical Science|June 14, 2021
Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic deliveryGayathri R Ediriweera, Joshua D Simpson, Adrian V Fuchs, et al.
Plos One|October 24, 2017
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft modelsMohamed A Alfaleh, Christopher B Howard, Ilya Sedliarou, et al.
ACS Central Science|June 4, 2020
Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific AntibodiesZachary H Houston, Jens Bunt, Kok-Siong Chen, et al.
Biomaterials|February 26, 2022
Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruptionPhillip W Janowicz, Zachary H Houston, Jens Bunt, et al.
Advanced Healthcare Materials|March 15, 2019
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific AntibodiesJiwei Cui, Yi Ju, Zachary H Houston, et al.
Pageof 5